Home prothrombin time monitoring: a literature analysis
- PMID: 15389909
- DOI: 10.1002/ajh.20161
Home prothrombin time monitoring: a literature analysis
Abstract
The anticoagulant activity of warfarin sodium is monitored by the prothrombin time (PT) using the international normalized ratio (INR). Standard oral anticoagulant therapy monitoring requires frequent patient visits to physicians' offices and/or laboratories to optimize warfarin dosage. Home PT monitoring by patients can increase testing frequency and may thus decrease complications associated with oral anticoagulant therapy. Clinical studies suggest that home PT monitoring is more effective than uncoordinated management and is as effective as care through specialized anticoagulation clinics for keeping INRs within a therapeutic range. There are accurate and reliable instruments available, but paramount to the success of home PT monitoring is sound patient selection, appropriate patient training, and consistent quality control.
Copyright 2004 Wiley-Liss, Inc.
Similar articles
-
Assessment of patient capability to self-adjust oral anticoagulant dose: a multicenter study on home use of portable prothrombin time monitor (COAGUCHECK).Haematologica. 2000 Aug;85(8):826-31. Haematologica. 2000. PMID: 10942929
-
Home INR monitoring of oral anticoagulant therapy in children using the CoaguChek S point-of-care monitor and a robust education program.Thromb Res. 2006;118(5):587-93. doi: 10.1016/j.thromres.2005.08.004. Epub 2005 Sep 15. Thromb Res. 2006. PMID: 16168465
-
Quality assurance program for whole blood prothrombin time-international normalized ratio point-of-care monitors used for patient self-testing to control oral anticoagulation.Thromb Res. 2004;113(1):35-40. doi: 10.1016/j.thromres.2004.01.009. Thromb Res. 2004. PMID: 15081563 Clinical Trial.
-
Anticoagulation monitoring part 1: warfarin and parenteral direct thrombin inhibitors.Ann Pharmacother. 2005 Jun;39(6):1049-55. doi: 10.1345/aph.1E118. Epub 2005 Apr 26. Ann Pharmacother. 2005. PMID: 15855245 Review.
-
Point of care monitors for oral anticoagulant therapy.Semin Thromb Hemost. 2004 Dec;30(6):697-702. doi: 10.1055/s-2004-861512. Semin Thromb Hemost. 2004. PMID: 15630676 Review.
Cited by
-
Protective Role of Silymarin on Hepatic and Renal Toxicity Induced by MTX Based Chemotherapy in Children with Acute Lymphoblastic Leukemia.Mediterr J Hematol Infect Dis. 2016 Sep 1;8(1):e2016043. doi: 10.4084/MJHID.2016.043. eCollection 2016. Mediterr J Hematol Infect Dis. 2016. PMID: 27648206 Free PMC article.
-
Evolving Paradigm of Prothrombin Time Diagnostics with Its Growing Clinical Relevance towards Cardio-Compromised and COVID-19 Affected Population.Sensors (Basel). 2021 Apr 9;21(8):2636. doi: 10.3390/s21082636. Sensors (Basel). 2021. PMID: 33918646 Free PMC article. Review.
-
Construction of a rabbit model with vinorelbine administration via peripherally inserted central catheter and dynamic monitoring of changes in phlebitis and thrombosis.Exp Ther Med. 2022 Mar;23(3):212. doi: 10.3892/etm.2022.11135. Epub 2022 Jan 11. Exp Ther Med. 2022. PMID: 35126715 Free PMC article.
-
Is patient self-testing a good thing?J Thromb Thrombolysis. 2010 Feb;29(2):214-8. doi: 10.1007/s11239-009-0414-3. J Thromb Thrombolysis. 2010. PMID: 19902148 No abstract available.
-
Factors determining patients' intentions to use point-of-care testing medical devices for self-monitoring: the case of international normalized ratio self-testing.Patient Prefer Adherence. 2013;7:1-14. doi: 10.2147/PPA.S38328. Epub 2012 Dec 28. Patient Prefer Adherence. 2013. PMID: 23300344 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources